These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 5314258)
1. Adverse reactions during treatment of Parkinson's disease with levodopa. Martin WE JAMA; 1971 Jun; 216(12):1979-83. PubMed ID: 5314258 [No Abstract] [Full Text] [Related]
2. L-dopa therapy in Parkinson's disease. Lipman IJ Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138 [No Abstract] [Full Text] [Related]
3. L-dopa. II. Br Med J; 1970 Nov; 4(5734):541-2. PubMed ID: 4099003 [No Abstract] [Full Text] [Related]
4. Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis. Fehling C Z Neurol; 1972; 202(3):197-208. PubMed ID: 4120049 [No Abstract] [Full Text] [Related]
5. [Results of treatment with levodopa and rehabilitative therapy in 10 cases of Parkinson's disease]. Paciaroni E; Raspa EG Sist Nerv; 1970; 22(2):153-61. PubMed ID: 5504554 [No Abstract] [Full Text] [Related]
6. A second report on Levodopa. Med Lett Drugs Ther; 1969 Sep; 11(18):73-5. PubMed ID: 5394281 [No Abstract] [Full Text] [Related]
7. Specific therapy in Parkinson's disease. Med J Aust; 1970 Oct; 2(14):612-3. PubMed ID: 5477804 [No Abstract] [Full Text] [Related]
9. A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease. Martin WE; Loewenson RB; Resch JA; Baker AB Neurology; 1974 Oct; 24(10):912-9. PubMed ID: 4606107 [No Abstract] [Full Text] [Related]
10. Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa. Godwin-Austen RB; Bergmann S; Frears CC Br Med J; 1971 Nov; 4(5786):522-4. PubMed ID: 4942463 [TBL] [Abstract][Full Text] [Related]
11. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University). Gutmann L; Martin JD; Gutrecht JA W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660 [No Abstract] [Full Text] [Related]
13. Parkinson's disease and levodopa. A five-year follow-up and review. Markham CH; Treciokas LJ; Diamond SG West J Med; 1974 Sep; 121(3):188-206. PubMed ID: 4606887 [No Abstract] [Full Text] [Related]
14. Side effects of L-dopa treatment. Greenburg J Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645 [No Abstract] [Full Text] [Related]
15. Treatment of parkinsonism with levodopa. Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999 [No Abstract] [Full Text] [Related]
16. L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area. Mars H; Libman I; Schwartz AM; Gillo-Joffroy L; Barbeau A Can Psychiatr Assoc J; 1972 Apr; 17(2):123-31. PubMed ID: 5036506 [No Abstract] [Full Text] [Related]
17. L-Dopa treatment in Parkinson's Disease. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969 [No Abstract] [Full Text] [Related]
18. [L-dopa and Parkinson's disease]. Barbeau A Union Med Can; 1970 Dec; 99(12):2195-7. PubMed ID: 5488646 [No Abstract] [Full Text] [Related]
19. L-Dopa in the treatment of parkinsonism. Calne DB Clin Pharmacol Ther; 1970; 11(6):789-801. PubMed ID: 4921292 [No Abstract] [Full Text] [Related]
20. [Collateral effects of therapy with L-dopa in Parkinson's disease]. Gomirato G; Perfetti CC; Ecari U Sist Nerv; 1970; 22(2):67-73. PubMed ID: 5504559 [No Abstract] [Full Text] [Related] [Next] [New Search]